Physics Contribution
A Longitudinal Evaluation of Partial Lung Irradiation in Mice by Using a Dedicated Image-Guided Small Animal Irradiator

https://doi.org/10.1016/j.ijrobp.2014.07.004Get rights and content

Purpose

In lung cancer radiation therapy, the dose constraints are determined mostly by healthy lung toxicity. Preclinical microirradiators are a new tool to evaluate treatment strategies closer to clinical irradiation devices. In this study, we quantified local changes in lung density symptomatic of radiation-induced lung fibrosis (RILF) after partial lung irradiation in mice by using a precision image-guided small animal irradiator integrated with micro-computed tomography (CT) imaging.

Methods and Materials

C57BL/6 adult male mice (n=76) were divided into 6 groups: a control group (0 Gy) and groups irradiated with a single fraction of 4, 8, 12, 16, or 20 Gy using 5-mm circular parallel-opposed fields targeting the upper right lung. A Monte Carlo model of the small animal irradiator was used for dose calculations. Following irradiation, all mice were imaged at regular intervals over 39 weeks (10 time points total). Nonrigid deformation was used to register the initial micro-CT scan to all subsequent scans.

Results

Significant differences could be observed between the 3 highest (>10 Gy) and 3 lowest irradiation (<10 Gy) dose levels. A mean difference of 120 ± 10 HU between the 0- and 20-Gy groups was observed at week 39. RILF was found to be spatially limited to the irradiated portion of the lung.

Conclusions

The data suggest that the severity of RILF in partial lung irradiation compared to large field irradiation in mice for the same dose is reduced, and therefore higher doses can be tolerated.

Introduction

Lung cancer remains the most common type of cancer worldwide, and strategies are needed to improve local tumor control (1). The dose-limiting toxicity of radiation therapy with or without drugs is acute stage radiation-induced lung pneumonitis or late stage radiation-induced lung fibrosis (RILF). Advances in radiation dose delivery such as stereotactic body radiation therapy and intensity modulated radiation therapy have been shown to minimize the rate of treatment complications by avoiding radiation to normal lung tissue 2, 3, 4. However, despite recognition of radiation-induced lung injury (RILI) as early as the use of radiation therapy itself, treatment strategies to alleviate lung toxicity have hitherto been largely ineffective (5).

Preclinical small animal models of RILI are a means to evaluate new treatment strategies that would be unethical to investigate in patients and allow for studies with large cohorts, transgenic animals, controlled experimental conditions, and accelerated results due to the shorter lifespans. The use of computed tomography (CT) imaging to noninvasively monitor changes in lung morphology, principally changes in lung density, due to RILI has been successfully applied in both clinical 6, 7, 8, 9 and preclinical studies 10, 11, 12, 13, 14, 15. However, most of these previous preclinical studies were performed using large radiation fields often covering the whole thorax, with relatively coarse clinical resolution CT imaging and limited knowledge of where radiation was delivered. The clinical utility of the results of these studies may be limited due to the radiation dose distributions being highly dissimilar to current radiation therapy practice.

Dedicated precision image-guided small animal irradiation (IR) devices are now available that better mimic clinical radiation therapy, making them potentially better suited to study and quantify RILI 16, 17, 18. These devices provide unparalleled targeting accuracy with registered CT irradiation technology that allows researchers to directly study the response of structures to the known regions of irradiation. Within this context, the focus of this study was to develop advanced methods including deformable registration, image segmentation, and full 3-dimensional (3D) accurate dose calculations for small radiation fields to quantify local changes in lung density following precision irradiation in mice. We aimed to place the results within the context of previous irradiation studies that did not make use of these advanced techniques. We used high-resolution micro-CT to monitor a large cohort of fibrosis-prone C57BL/6 mice for an extended period of 39 weeks of observation, which is longer than that of any previous study.

Section snippets

Selection of subjects

C57BL/6 adult male mice (n=76) at 12 weeks of age entered the study and are known to be prone to fibrosis 19, 20. Animal experiments were in accordance with local institutional guidelines for animal welfare and approved by the Animal Ethical Committee of the University (number 2012-006). Animals were divided into 6 groups, corresponding to 6 radiation dose levels, with each group containing at least 11 animals. Before and subsequent to irradiation, all mice were imaged using micro-CT at regular

Results

Animals appeared healthy for the duration of the study; their body weights steadily increased over the 39-week study endpoint (see supplementary Fig. SA). The whole cohort of mice was imaged and irradiated within 17 hours spread over 2 days. In the subsequent micro-CT imaging follow-up, we achieved a throughput time of 6 minutes per animal per imaging session. In a subset analysis of 6 mice, animal breathing remained principally in a state of maximum exhalation with the diaphragm relaxed, with

Discussion

This study demonstrates the feasibility of large animal cohort radiation studies that are more representative of clinical irradiation schemes. Following the seventh week postirradiation, C57/BL6 male mice irradiated with 5-mm parallel-opposed beams of prescription doses greater than 10 Gy exhibited a steady increase in lung density most pronounced for the 20-Gy group, having a maximum difference of 120 HU at the 39th week endpoint compared to the zero dose group. We have shown that partial lung

Conclusions

Presently, we are faced with a wealth of new compounds that may be combined with radiation therapy; nearly none of the novel drugs has been investigated in animals with regard to normal tissue damage. Indeed, results from preclinical animal experiments cannot be translated directly to humans, but at least an indication of the side effects as well as the genetic or mechanistic basis for the interaction may arise. In that context, normal tissue work may be more readily extrapolated from mice to

References (34)

  • E.L. Travis et al.

    Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung

    Int J Radiat Oncol Biol Phys

    (1997)
  • J. Cho et al.

    High dose-per-fraction irradiation of limited lung volumes using an image-guided, highly focused irradiator: Simulating stereotactic body radiotherapy regimens in a small-animal model

    Int J Radiat Oncol Biol Phys

    (2010)
  • G. Stroian et al.

    Local correlation between Monte Carlo dose and radiation-induced fibrosis in lung cancer patients

    Int J Radiat Oncol Biol Phys

    (2008)
  • J. Ferlay et al.

    Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

    Int J Cancer

    (2010)
  • T.B. Lanni et al.

    Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer

    Am J Clin Oncol

    (2011)
  • W.I. Jang et al.

    High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma

    Radiat Oncol

    (2013)
  • D. De Ruysscher et al.

    Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics

    Acta Oncol

    (2013)
  • Cited by (0)

    Financial support for the purchase and operation of the microirradiator was provided by Marie Curie grant PIRG03-GA-2008-230911, Netherlands Organisation for Health Research and Development grant 40-00506-98-9019, and the GROW research institute. Financial support for the study was provided by Boehringer-Ingelheim International GmbH grant 43040512. PVG is supported by a 3 year Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.

    P.V. Granton and L. Dubois contributed equally to this work.

    Conflict of interest: none.

    View full text